Cointime reports: Johnson & Johnson plans to acquire Ollin Biosciences for up to $3.4 billion, with the deal potentially announced as soon as Monday. The transaction would mark one of the largest recent acquisitions in the biotech sector. No further terms or closing timeline were disclosed.
J&J to acquire Ollin Biosciences for up to $3.4B
Share on WeChat
Open WeChat → Scan → then tap "…" to send to a chat or Moments.
Tap "…" in the top-right corner to send to a chat or share to Moments.
Related News
2h ago
BlackRock’s IBIT logs 11 straight days of net outflows
3h ago
Strategy Removed from MSCI Indexes, Effective After Nov 30 Close
8h ago
Global equity funds draw $50.99bn weekly inflow, highest in seven weeks
8h ago
Petition with 152,265 signatures calls for Jensen Huang’s return as Nvidia CEO
8h ago
Nikkei 225 futures rise 0.75% in early trading
8h ago
US equity funds post second straight weekly inflow, $6.6B